- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09.09. | Zomedica Corp.: Zomedica Announces "Fourth Friday at Four" Webinar on September 25, 2026: Inside Zomedica's Marketing Engine: How Demand Becomes Revenue | 718 | ACCESS Newswire | September session to spotlight how Zomedica's marketing function creates demand, equips the field, and supports utilization across the company's diagnostic and therapeutic portfolios ANN ARBOR, MI /... ► Artikel lesen | |
| 13.08. | Zomedica Corp.: Zomedica Announces Strategic Collaboration with Boehringer Ingelheim Animal Health Canada Inc. to Expand Equine Endocrine Diagnostic Testing Using TRUFORMA Platform | 862 | ACCESS Newswire | Collaboration with one of the world's largest animal health companies expected to accelerate TRUFORMA adoption, expand installed base, and drive recurring diagnostic revenue in Canada ANN ARBOR, MI... ► Artikel lesen | |
| 11.08. | Zomedica Corp.: Zomedica Announces "Fourth Friday at Four" Webinar on August 28, 2026: Zomedica International: Building a Global Platform for Veterinary Innovation | 828 | ACCESS Newswire | August session to spotlight Zomedica's international expansion strategy, distributor infrastructure, global market opportunity, and the commercial leadership driving growth across five continents ANN... ► Artikel lesen | |
| 05.08. | Zomedica Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 05.08. | Zomedica Corp.: Zomedica Announces Record Second Quarter Revenue of $9.5 Million, Up 37% Year-Over-Year, Net Loss Reduced 49%, with $44.1 Million in Liquidity | 494 | ACCESS Newswire | Zomedica surpasses $9 million in second quarter revenue for the first time while extending its record of consecutive year-over-year revenue growth to 22 quarters. ANN ARBOR, MI / ACCESS Newswire / August... ► Artikel lesen | |
| 05.08. | Zomedica Corp. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 04.08. | Zomedica Corp.: Zomedica Launches the PulseVet Acoustic Muffler Accessory for PulseVet Shock Wave System | 400 | ACCESS Newswire | The accessory reduces sound in the treatment environment while maintaining the trusted efficacy of PulseVet shock wave therapy ANN ARBOR, MI / ACCESS Newswire / August 4, 2026 / Zomedica Corp. (OTCQB:ZOMDF)... ► Artikel lesen | |
| ZOMEDICA Aktie jetzt für 0€ handeln | |||||
| 15.07. | Zomedica Corp.: Zomedica Announces "Fourth Friday at Four" Webinar on July 24, 2026: Zomedica's Sales Organization - From Strategy to the Clinic | 541 | ACCESS Newswire | July session to spotlight the specialized, coordinated commercial organization that turns product innovation into clinical adoption, sustained utilization, and long-term recurring revenue ANN ARBOR... ► Artikel lesen | |
| 25.06. | Zomedica Corp.: Zomedica's Assisi Loop Products Designated "Fear Free" as Alliance to Advance Low Stress Care and Pet Wellbeing Continues with Fear Free, LLC | 403 | ACCESS Newswire | Collaboration with Fear Free and Zomedica reinforces Assisi Loop tPEMF therapy as a low-stress option for pets. ANN ARBOR, MI / ACCESS Newswire / June 25, 2026 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica"... ► Artikel lesen | |
| 11.06. | Zomedica Corp. - 8-K, Current Report | 2 | SEC Filings | ||
| 10.06. | Zomedica Corp.: Zomedica Announces "Fourth Friday at Four" Webinar on June 26, 2026: The Five Pillars of Zomedica - Framework for Clinical Value and Shareholder Returns | 430 | ACCESS Newswire | June session to present the strategic framework behind every Zomedica product and investment decision, connecting pet care outcomes, veterinary practice performance, and long-term recurring revenue... ► Artikel lesen | |
| 20.05. | Zomedica Corp.: Zomedica's PulseVet System Repeats as Official Shock Wave of the United States Eventing Association | 457 | ACCESS Newswire | Collaboration with USEA for Zomedica's PulseVet shock wave system will increase brand awareness among Eventing enthusiasts. ANN ARBOR, MI / ACCESS Newswire / May 20, 2026 / Zomedica Corp. (OTCQB:ZOMDF)... ► Artikel lesen | |
| 14.05. | Zomedica Corp.: Zomedica Announces "Fifth Friday at Four" Webinar on May 29th: First Quarter 2026 Financial Results and a Deep Dive into the Companion Animal VetTech Market | 1.020 | ACCESS Newswire | May session to review Q1 2026 financial results alongside an investor-focused look at the companion animal market for veterinary technology and Zomedica's integrated small-animal portfolio, spanning... ► Artikel lesen | |
| 06.05. | Zomedica Corp.: Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity | 1.017 | ACCESS Newswire | Zomedica surpasses $8 million in first quarter revenue for the first time and delivers record year-over-year revenue for 21st straight quarter. ANN ARBOR, MI / ACCESS Newswire / May 6, 2026 / Zomedica... ► Artikel lesen | |
| 06.05. | Zomedica reports Q1 results | 7 | Seeking Alpha | ||
| 06.05. | Zomedica Corp. - 8-K, Current Report | 3 | SEC Filings | ||
| 06.05. | Zomedica Corp. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 16.04. | Zomedica Corp.: Zomedica Announces "Fourth Friday at Four" Webinar on April 24th: A Behind-the-Scenes Look at Manufacturing Excellence and Operational Scale | 603 | ACCESS Newswire | April session to take investors inside Zomedica's manufacturing operations - showcasing quality systems, automation, and teams driving scalable product fulfillment providing substantial margins ANN... ► Artikel lesen | |
| 18.03. | Zomedica Corp.: Zomedica Announces Strategic Collaboration with Boehringer Ingelheim to Expand Equine Endocrine Diagnostic Testing Using TRUFORMA Platform | 846 | ACCESS Newswire | Collaboration with one of the world's largest animal health companies expected to accelerate TRUFORMA adoption, expand installed base, and drive recurring diagnostic revenue ANN ARBOR, MI / ACCESS Newswire... ► Artikel lesen | |
| 16.03. | Zomedica Corp.: Zomedica Announces Record Fourth Quarter Revenue of $10.5 Million and Full Year Revenue of $32.0 Million for 2025, Reflecting 17% Annual Growth; Achieves 68% Gross Margin and Maintains $53.3 Million in Liquidity | 557 | ACCESS Newswire | Zomedica surpasses $10 million in quarterly revenue for the first time and delivers record year-over-year revenue for 20th straight quarter. ANN ARBOR, MI / ACCESS Newswire / March 16, 2026 / Zomedica... ► Artikel lesen |
1 2 Weiter >>
37 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ALIGNMENT HEALTHCARE | 8,710 | 0,00 % | Alignment Healthcare extends retreat, falls an additional 16% | ||
| BETA BIONICS | 22,180 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces FDA Clearance of Mint, the Company's Transformative Patch Pump, and Unveils 3D Intelligence as its Next-Generation Insulin Dosing Algorithm | Mint features a new and innovative patch pump architecture Full Mint U.S. commercialization expected to begin in Q1 2027 Manufacturing capacity expected to produce at least 1.5 million disposable... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 12,790 | 0,00 % | LifeStance Health auf Morgan Stanley Konferenz: Wachstum und Margen im Fokus | ||
| AVEANNA HEALTHCARE | 14,260 | 0,00 % | Aveanna Healthcare auf dem Deutsche Bank Healthcare Summit 2026: Neuausrichtung auf Wachstumskurs | ||
| BRIGHTSPRING HEALTH SERVICES | 58,97 | +0,02 % | Here's Why You Should Add BrightSpring Stock to Your Portfolio Now | ||
| GENEDX | 97,48 | 0,00 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| HEARTFLOW | 48,330 | 0,00 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,450 | +0,23 % | BERENBERG stuft Siemens Healthineers auf 'Hold' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat Siemens Healthineers mit einem Kursziel von 40 Euro auf "Hold" belassen. Der Medizintechnik- und Life-Science-Sektor bleibe fundamental attraktiv... ► Artikel lesen | |
| FRESENIUS | 45,950 | -0,41 % | EQS-DD: Fresenius SE & Co. KGaA: Sara Hennicken, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
10.09.2026 / 11:59... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,850 | -0,45 % | EQS-PVR: Fresenius Medical Care AG: Veröffentlichung über Erwerb oder Veräußerung eigener Aktien nach § 40 Abs. 1 Satz 2 WpHG | EQS Stimmrechtsmitteilung: Fresenius Medical Care AG
Fresenius Medical Care AG: Veröffentlichung über Erwerb oder Veräußerung eigener Aktien nach § 40 Abs. 1 Satz 2 WpHG
10.09.2026... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 19,450 | 0,00 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BILLIONTOONE | 103,51 | 0,00 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 20,360 | 0,00 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 1,210 | 0,00 % | Tempest Therapeutics: Tempest Secures Exclusive Option to License Clinical-Stage CD7-Targeted Lentiviral In Vivo CAR-T Platform | -Transaction complements Tempest's existing CD7-targeted lipid nanoparticle in vivo CAR-T delivery platform, which is planned to enter the clinic later this year -Lead BCMA/GPRC5D dual-targeting in... ► Artikel lesen | |
| PROGYNY | 27,390 | +0,04 % | Progyny vor dem Boom?: Wells Fargo sieht bei dieser "Kinderwunsch-Aktie" 42 % Kurspotenzial | © Foto: SOPA Images - Sipa USAWells Fargo traut Progyny 42 Prozent Kurspotenzial zu. Das Geschäft mit Kinderwunsch-Leistungen könnte jetzt zum großen Wachstumstreiber werden Enthaltene Werte: US74340E1038Den... ► Artikel lesen |
ZOMEDICA CORP gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ZOMEDICA CORP finden Sie auf Wallstreet Online.